Kyoto Prefectural University of Medicine · Faculty of Medicine

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer.
• Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer.
• Fluorescence-based discrimination of breast cancer cells by direct exposure to 5-aminolevulinic acid.
• Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer

• 光線力学診断による乳癌蛍光細胞診断技術の開発

• Official profile